Health
Has The Market Overpriced Moderna’s Vaccine? – Forbes
Moderna stock has jumped by about 4x this year adding over $20 billion in market value, as investors bet that a successful Covid-19 vaccine could generate windfall profits for the clinical-stage biotech company. Is this jump in valuation warranted? We don’t t…
Medical syringe is seen with Moderna company logo displayed on a screen in the background in this ……
Continue Reading
-
General13 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
General19 hours agoGold Coast warned it faces traffic gridlock without major shift to public transport
-
Noosa News22 hours agoDicky Bill salad greens farms enter administration with 180 job cuts just before Christmas
-
Business24 hours ago1 unstoppable artificial intelligence (AI) stock to buy before it soars more than 300%, according to a Wall Street analyst